Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Osteoporosis
Literature
1.
Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O (2017) Clinical Features of 24 Patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32(6):1291–1296CrossRef
2.
Papapoulos SE, Cremers SC (2007) Prolonged bisphosphonate release after treatment in children. N Engl J Med 356(10):1075–1076CrossRef
3.
Anastasilakis AD, Evangelatos G, Makras P, Iliopoulos A (2020) Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation. Bone Rep 12:100267CrossRef
4.
Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC (2017) Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. Bone 105:11–17CrossRef
5.
Koller G, Goetz V, Vandermeer B, Homik J, McAlister FA, Kendler D, Ye C (2020) Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteoporos Int 31(11):2093–2102CrossRef
6.
Fahrleitner-Pammer A, Papaioannou N, Gielen E, Feudjo Tepie M, Toffis C, Frieling I, Geusens P, Makras P, Boschitsch E, Callens J, Anastasilakis AD, Niedhart C, Resch H, Kalouche-Khalil L, Hadji P (2017) Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Arch Osteoporos 12(1):58CrossRef
7.
Pal R, Bhadada SK (2020) Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metab Syndr 14(5):767–771CrossRef
8.
Paskins Z, Crawford-Manning F, Bullock L, Jinks C (2020) Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation? Osteoporos Int 31(9):1629–1632CrossRef
Metadata
Title
Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic
Authors
Roland Kocijan
Martina Behanova
Berthold Reichardt
Judith Haschka
Annemarie Kocijan
Jochen Zwerina
Publication date
01-12-2021
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2021
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-021-00904-x

Other articles of this Issue 1/2021

Archives of Osteoporosis 1/2021 Go to the issue

Original Article

The relationship between serum folate and grip strength in American adults

Original Article

Association between vitamin D and bone mineral density in Japanese adults: the Unzen study

Original Article

Four-month outcome after proximal femur fractures and influence of early geriatric rehabilitation: data from the German Centres of Geriatric Trauma DGU

Case Report

Teriparatide in individuals with a prior history of radiation therapy—a case series

Original Article

Relationship between number of radiological risk factors for delayed union after osteoporotic vertebral fracture and clinical outcomes

Original Article

Incidence of and risk factors for hip fracture in Nagasaki, Japan from 2005 to 2014